MEDIKINET MR 20 MG MODIFIED-RELEASE CAPSULES
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
METHYLPHENIDATE HYDROCHLORIDE 20 MG
Available from:
MEDILINE LTD.
ATC code:
N06BA04
Pharmaceutical form:
MODIFIED RELEASE CAPSULES
Administration route:
PER OS
Manufactured by:
MEDICE ARZNEIMITTEL PUETTER GMBH & CO.KG, GERMANY
Therapeutic group:
METHYLPHENIDATE
Therapeutic indications:
Medikinet Modified Release Capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (ADHD) in children over 6 years of age when remedial measures alone prove insufficient. Treatment must be under the supervision of a specialist in childhood behavioural disorders. Diagnosis should be made according to DSM-IV criteria or the guidelines in ICD-10.
Authorization date:
2011-05-01
